$103.29
-0.07% (Daily)
Market Cap
$19.62B
Revenue
$3.25B
Rank by MCap
#1925
Sector
Healthcare
Industry
Diagnostics & Research
CEO
Mr. Kevin T. Conroy J.D.
Headquarters
Madison, WI
Employees
7,100
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. It offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer; Cologuard Plus Tests; Cancerguard Test; and Genetic Testing. The company also provides Oncotype DX Breast Recurrence Score Test; Oncotype DX Breast DCIS Score Test; Oncotype DX Colon Recurrence Score Test; Oncodetect...
Loading chart…